Business & Policy News

GRAIL announces collaborations with three industry giants to evaluate its platform in cancer MRD testing

Company shares plans to spin out oncology business and retain severe genetic disease business

The companies are aiming to develop a new production-scale platform to expand clinical adoption of whole-genome sequencing

Lantern Pharma kicks off ADC program to develop treatments for various cancer types

Distributed Bio adds large-molecule discovery platform to Charles River's repertoire

The companies will advance the gonadotropin-releasing hormone receptor antagonist in advanced prostate cancer and two women's health indications

The deal nets Servier a clinical oncology portfolio and will expand its U.S. footprint

Horizon grants Sanyou two commercial licenses to its CHOSOURCE platform

The acquisition nets Merck a pipeline of oncology programs as well as CD24Fc, OncoImmune's lead candidate for the treatment of COVID-19